# Quantum-Si Detects 19 Amino Acids in Proteus Program, Targeting 2027 Launch

- URL: https://stocks.freetheai.org/news/quantum-si-detects-19-amino-acids-in-proteus-program-targeting-2027-launch-ead8a4
- Published: 2026-10-08T20:05:00Z
- Category: company_news; sentiment: mixed; impact: medium
- Symbols: [NASDAQ:QSI](https://stocks.freetheai.org/symbols/NASDAQ-QSI)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

Quantum-Si Incorporated (QSI) has successfully detected 19 amino acids within its Proteus development program. The proteomics company is now integrating this 19-amino-acid detection technology into a developmental sequencing kit designed for its Proteus instruments. Despite the announcement, shares of the company fell 4.69% to 1.22 USD on Thursday.

This development marks a step forward from the company's previous test results, which demonstrated improvements in sequencing performance using an 18-amino-acid kit. By expanding the detection range to 19 amino acids, the company aims to further boost the sequencing capabilities of the Proteus platform. This progress supports the company's efforts to finalize its technology ahead of its planned commercial rollout.

The company expects to demonstrate detection of all 20 amino acids by the end of 2026. It is working toward a commercial launch of the Proteus platform in the second quarter of 2027. Investors will likely watch whether the company hits these development deadlines and how the technology performs in upcoming R&D testing.

## Key points

- Quantum-Si successfully demonstrated the detection of 19 amino acids in its Proteus development program.
- The company is integrating this capability into a developmental sequencing kit for Proteus instruments.
- Management remains confident in detecting all 20 amino acids by the end of 2026.
- Quantum-Si is targeting a commercial launch of the Proteus platform in the second quarter of 2027.
- Shares of Quantum-Si fell 4.69% to 1.22 USD following the announcement.

## Questions and answers

### What milestone did Quantum-Si achieve in its Proteus program?

The company demonstrated the detection of 19 amino acids and is working to deploy this capability into a developmental sequencing kit.

### When does Quantum-Si plan to launch the Proteus platform commercially?

The company is targeting a commercial launch of the Proteus platform in the second quarter of 2027.

### What is Quantum-Si's next goal for amino acid detection?

Quantum-Si aims to demonstrate the detection of all 20 amino acids by the end of 2026.